Original Article
Significant Difference in the Serum Aspartate Aminotransferase Levels Across the Diagnostic Categories of Various Cardiac Diseases
Year: 2020 | Month: Jan-Jun | Volume 7 | Issue 1
1.Weng SF, Kai J, Guha IN, Qureshi N. The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment. Open Heart 2015;2:e000272.
View at Google Scholar View at PUBMED2.Smita D, Dandekar S, Chaturvedi S. Increased serum alkaline phosphatase activity in different cardiac diseases. Int J Recent Sci Res 2018;9:24262-4.
View at Google Scholar3.Upadhyay RK. Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids 2015;2015:971453.
View at Google Scholar View at PUBMED4.Shen J, Zhang J, Wen J, Ming Q, Zhang J, Xu Y. Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease. Int J Clin Exp Med 2015;8:4399- 404.
View at Google Scholar View at PUBMED5.Cecilia S, Hultcrantz R. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up 1. Hepatology 2010;51:595-602.
View at Google Scholar View at PUBMED6.Kasper DL, Braunwald E, Fauci H. Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2004. p. 1301-486.
View at Google Scholar7.Masoudkabir F, Karbalai S, Vasheghani-Farahani A, Aliabadi LL, Boroumand MA, Aiatollahzade-Esfahani F, et al. The association of liver transaminase activity with presence and severity of premature coronary artery disease. Angiology 2011;62:614-9.
View at Google Scholar View at PUBMED8.Han X, Boisvert WA. Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost 2015;113:505-12.
View at Google Scholar View at PUBMED9.Cagli K, Basar FN, Tok D, Turak O, Basar O. How to interpret liver function tests in heart failure patients? Turk J Gastroenterol 2015;26:197-203.
View at Google Scholar View at PUBMED